Corex
  • Services
  • Global network
  • About us
  • Knowledge hub

From early-stage research to post-trial access and commercial distribution

View All Services
Clinical Trial Supply & Logistics
Clinical Trial Supply & Logistics
  • Clinical Trial Logistics
  • Clinical Trial Supply
  • Courier Services & Preconditioned Temperature Controlled Packaging
  • GxP-Compliant Cold Chain Transport & Storage
  • Decentralised Clinical Trials & Direct-to-Patient Logistics
  • Labelling of Medicinal Products
  • Laboratory Kits Preparation
  • Protocol Review & Project Management
Medicines Access & Patient-Oriented Services
Medicines Access & Patient-Oriented Services
  • Managed Access Programme (MAP)
  • Named Patient Programme (NPP)
  • Expanded Access Programme (EAP)
  • Post-Trial Access (PTA)
  • Compassionate Use Programme (CUP)
  • Patient-Oriented Services
Regulatory & Importation Services
Regulatory & Importation Services
  • Brokerage Services
  • Import Unlicensed Medicines, Clinical Supplies & Laboratory Equipment
  • Importer of Record (IoR) Services
  • Regulatory Support and Customs Clearance
Storage & Distribution <br>Solutions
Storage & Distribution
Solutions
  • Quarantine Storage
  • Cryogenic Transport & Storage
  • Vaccine Delivery & Storage
  • Returns, Archiving and Destruction of Materials
  • Local and International Distribution
News
Events
Media Center
Contact Our Team

Latest News

COREX Appoints Jamie Beaumont as Global Head of Clinical Trials Sourcing

01.09.2026
COREX Appoints Jamie Beaumont as Global Head of Clinical Trials Sourcing

Other News

Lowering the price of health — COREX

Lowering the price of health

Medicines set to be 40% cheaper in Georgia, under new government pricing policy
05.12.2022
Vaccine Refusal — COREX

Vaccine Refusal

Kazakhstan will refuse an offer of humanitarian aid from the US in the form of COVID-19 vaccines
30.11.2022
EA in the EU — COREX

EA in the EU

Most EU member states have special programmes which facilitate early patient access to new medicines through a national authority
21.11.2022
Direct to Patient — COREX

Direct to Patient

If we can help people deal with their illnesses in any way, it’s a very worthwhile thing to do
14.11.2022
Cancer Trial Reporting — COREX

Cancer Trial Reporting

A new analysis of Cancer Clinical Trial reporting during the pandemic, gives us some interesting insights into how decentralisation will work
02.12.2022
Hemgenix Approved — COREX

Hemgenix Approved

Hemgenix, a new gene therapy to treat Haemophilia B, has just received approval from the FDA
28.11.2022
Mental Health First — COREX

Mental Health First

Emotional Trials — how clinical research subjects can face a mental load and what can be done to lighten it
16.11.2022
The COREX expert team at CPhI — COREX

The COREX expert team at CPhI

CPhI 2022, the main Pharma industry exhibition, which took place in Frankfurt from November 1st to 3rd
10.11.2022
  • 1
  • ...
  • 7
  • 8
  • 9
  • 10
  • 11
  • ...
  • 23

Contact the COREX Team

Have a question, request, or need support across multiple services?

Fill in the form — our team will get back to you shortly with the right solution.

Thanks for reaching out to COREX!

Your message is on its way to our team.

We’ll be in touch very soon — usually within one business day.

Until then, feel free to browse our services or learn more about where we operate

Back to Homepage
The partner of choice
for clinical trial professionals

Suite 314, Guinness Enterprise Centre, Taylor’s Lane Dublin 8, Dublin 8, Dublin, D08 KT7F, Ireland.

+353 1 913 6967

info@corexpharm.com

  • Services
  • Global network
  • About us
  • Contacts
  • News
Privacy Policy
Cookie Policy
Terms and Conditions
Copyright © 2026 COREX - All rights reserved
Your cookie choice
We use strictly necessary cookies to make our website work. With your consent, we also use functional and analytics cookies to provide optional features, understand how visitors use the site and improve its performance.
Corex
Cookie preferences
Choose which optional cookies and similar technologies we may use. Strictly necessary cookies are always active. Optional categories are off by default.
Required for website security, requested functions and remembering your cookie choices. These technologies cannot be switched off through this preference centre.
These cookies and similar technologies support optional features, such as chat and embedded content. If you do not allow them, some optional features may be unavailable, but the core website will continue to work.
These cookies and similar technologies help us understand how visitors use our website, measure performance and identify usability issues. They may collect information about page visits, interactions, browser or device details and pseudonymous identifiers.